Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 21 to 30 of 39

TitleReference numberPublishedLast updated
Total distal radioulnar joint replacement for symptomatic joint instability or arthritisHTG451
Sarilumab for moderate to severe rheumatoid arthritisTA485
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Baricitinib for moderate to severe rheumatoid arthritisTA466
Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDsTA445
Ustekinumab for treating active psoriatic arthritisTA340
Apremilast for treating active psoriatic arthritisTA433
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failedTA375
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritisTA373

Results per page

  1. 10
  2. 25
  3. 50
  4. All